Anlon Healthcare
add_icon

Anlon Healthcare

113.15
+0.08
(0.07%)
Market Cap
601.41 Cr
PE Ratio
17.40
Volume
74,315.00
Day High - Low
114.39 - 111.02
52W High-Low
172.75 - 90.78
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
601.41 Cr
EPS
6.37
PE Ratio
17.40
PB Ratio
2.81
Book Value
40.32
EBITDA
32.40
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
25.51
Debt to Equity
1.46
Forecast For
Actual

Company News

View All News
Caret
positive
Anlon Healthcare Limited successfully acquired 56.67% equity stake in Bizotic Life Science Private Limited on March 20, 2026, making it a subsidiary under SEBI regulations.
neutral
Anlon Healthcare Limited announces analyst/investor meeting with S. N. Damani Group scheduled for March 21, 2026, featuring plant visit and management interaction at Rajkot facility.
neutral
Neomile Growth Fund – Series I reduces its holding in Anlon Healthcare Limited from 5.16% to 4.40% through open market transactions, disposing 4,07,255 shares between March 8-10, 2026.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,693.60
#1 4,06,351.37
37.86
#1 54,729.00
9.71
#1 10,980
16.07
37.98
5,856.50
1,55,471.67
63.26
9,712.00
18.67
2,191
-1.02
33.24
3,987.20
1,34,944.97
61.20
11,539.40
6.99
1,911
26.24
32.75
2,274.50
1,03,954.48
22.26
22,909.50
13.74
3,306
#1 37.44
47.35
1,217.30
1,01,601.09
18.27
33,741.20
16.73
5,725
-15.28
39.36
1,192.40
96,319.77
21.31
28,409.50
7.12
5,291
-57.18
26.86
864.25
86,963.77
#1 17.29
23,511.00
18.55
4,615
-0.32
41.42
1,998.50
82,499.09
45.81
12,744.20
#1 20.90
2,007
7.65
41.40
1,333.70
77,461.51
22.37
32,345.60
9.43
3,484
7.59
64.38
5,258.00
62,867.28
25.87
13,458.30
3.70
2,216
1.90
42.54

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
80.66 %
Net Income Growth
111.34 %
Cash Flow Change
-598.14 %
ROE
-44.45 %
ROCE
43.74 %
EBITDA Margin (Avg.)
15.12 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
16
58
113
67
121
170
Expenses
21
52
101
51
88
121
EBITDA
-5
6
13
16
32
50
Operating Profit %
-33 %
9 %
11 %
23 %
27 %
29 %
Depreciation
2
2
2
2
2
2
Interest
3
4
4
4
4
4
Profit Before Tax
-10
-0
7
10
27
44
Tax
0
0
1
0
6
9
Net Profit
-10
-0
6
10
21
35
EPS in ₹
-8.53
-0.09
4.85
6.68
6.37
8.40

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
71
85
112
128
181
Fixed Assets
29
27
26
27
23
Current Assets
40
58
86
101
159
Capital Work in Progress
0
0
0
0
0
Investments
0
2
4
1
1
Other Assets
43
56
82
100
158
Total Equity & Liabilities
71
85
112
128
181
Current Liabilities
31
29
44
50
60
Non Current Liabilities
38
55
61
57
41
Total Equity
2
2
7
21
80
Reserve & Surplus
-10
-10
-5
5
41
Share Capital
12
12
12
16
40

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-2
1
-1
2
-1
Investing Activities
-3
-0
-0
-3
3
Operating Activities
-15
-2
-3
-3
-23
Financing Activities
16
3
2
8
19

Share Holding

% Holding
Oct 2024
Apr 2025
Jun 2025
Aug 2025
Sept 2025
Dec 2025
Promoter
70.26 %
70.26 %
52.68 %
70.26 %
52.68 %
52.68 %
FIIs
0.00 %
0.00 %
14.42 %
0.00 %
0.00 %
0.23 %
DIIs
0.00 %
0.00 %
4.35 %
0.00 %
2.83 %
4.49 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
14.64 %
0.00 %
20.73 %
23.58 %
Others
29.74 %
29.74 %
13.92 %
29.74 %
23.75 %
19.02 %
No of Share Holders
109
131
9,125
135
9,126
11,412

Announcements

Closure of Trading Window10 days ago
Announcement under Regulation 30 (LODR)-Updates on AcquisitionMar 20, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMar 18, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Mar 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 11, 2026
Shareholder Meeting / Postal Ballot-Notice of Postal BallotMar 09, 2026
Corporate Action-Board to consider Bonus IssueMar 06, 2026
Corporate Action-Intimation of Sub division / Stock SplitMar 06, 2026
Board Meeting Outcome for Outcome Of Board Meeting Of Anlon Healthcare Limited Held On Friday March 06 2026Mar 06, 2026
Closure of Trading WindowMar 02, 2026
Board Meeting Intimation for Stock Split And Issue Of Bonus SharesMar 02, 2026
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsFeb 27, 2026
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptFeb 24, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeFeb 19, 2026
Announcement under Regulation 30 (LODR)-Investor PresentationFeb 19, 2026
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 13, 2026
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportFeb 12, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 11, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseFeb 10, 2026
Approval Of Appointment Of Mr. Naimish Dilipbhai Bhatt As A Chief Financial Officer Of The Company.Feb 09, 2026
Approval Of Resignation Of Mr. Shailesh Kantilal Thakkar Independent Director Of The Company.Feb 09, 2026
Appointment Of Mr. Kishan Vinodkumar Raja As A Independent DirectorFeb 09, 2026
Announcement under Regulation 30 (LODR)-Resignation of DirectorFeb 09, 2026
Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)Feb 09, 2026
Anlon Helthcare Limited_Financial Results For The Quarter Ended December 31 2025Feb 09, 2026
Board Meeting Outcome for Outcome Of Board Meeting For The Approval Of Financial Results For The Quarter Ended December 31 2025Feb 09, 2026
The Company Has Purchased A Commercial Office At Ahmedabad Gujarat And Shall Be Used For Marketing Office.Feb 05, 2026
Board Meeting Intimation for Consideration And Approve The Financial Results For The Quarter Ended December 31 2025 Feb 03, 2026
Intimation As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (The Listing Regulations) - Development Of New ProductJan 28, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 09, 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Jan 09, 2026
Announcement With Continuation Of Our Earlier Intimation Dated December 02 2025 Regarding The Execution Of Share Purchase Agreement Dated December 2 2025.Jan 09, 2026
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportJan 07, 2026
Shareholder Meeting / Postal Ballot-Outcome of Postal_BallotJan 07, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 07, 2026
Closure of Trading WindowDec 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationDec 23, 2025
Announcement As Per Reg. 30 Of SEBI (LODR) Regulation 2015Dec 19, 2025
Results-Delay in Financial ResultsDec 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationDec 09, 2025
Shareholder Meeting / Postal Ballot-Notice of Postal BallotDec 08, 2025
Board Meeting Outcome for Held On Friday December 05 2025Dec 05, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsDec 02, 2025
Announcement under Regulation 30 (LODR)-Memorandum of Understanding /AgreementsNov 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 25, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptNov 24, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeNov 19, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationNov 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationNov 14, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationNov 13, 2025

Technical Indicators

RSI(14)
Neutral
45.02
ATR(14)
Less Volatile
6.29
STOCH(9,6)
Neutral
22.41
STOCH RSI(14)
Neutral
20.73
MACD(12,26)
Bearish
-0.09
ADX(14)
Weak Trend
13.50
UO(9)
Bearish
35.71
ROC(12)
Downtrend And Accelerating
-2.73
WillR(14)
Oversold
-87.78